WHO / UGANDA EBOLA END
11-Jan-2023
00:02:40
WHO Director-General marked today the end of the Ebola outbreak in Uganda, four months after the first cases were reported, saying the country “was able to use proven public health tools to contain the outbreak.” WHO
Subject to the Terms of Usages of UNifeed, UNifeed materials are available free of charge for news purposes only. UNifeed materials may not be sold or redistributed to third parties without the prior written consent of the UN or the UN entity which is source of the UNifeed material. All users of UNifeed materials must provide due credit to the United Nations or any UN entity source(s) in their use and broadcast of UNifeed materials.
Size
Format
Acquire
DESCRIPTION
STORY: WHO / UGANDA EBOLA END
TRT: 2:40
SOURCE: WHO
RESTRICTIONS: NONE
LANGAUGE: ENGLISH / NATS
DATELINE: SEE SHOTLIST
TRT: 2:40
SOURCE: WHO
RESTRICTIONS: NONE
LANGAUGE: ENGLISH / NATS
DATELINE: SEE SHOTLIST
SHOTLIST
DATELINE:
FILE – WHO – KAMPALA
1. Various shots, Kampala
11 JANUARY 2023, GENEVA, SWITZERLAND
2. SOUNDBITE (English) Dr Tedros Adhanom Ghebreyesus, Director-General, WHO:
“Today marks the end of the Ebola outbreak in Uganda, four months after the first cases were reported. I congratulate the government, the people of Uganda and health workers, some of whom lost their lives, for their leadership and dedication in bringing this outbreak to an end. We thank donors and partners for swiftly mobilizing resources, and vaccine developers for making candidate vaccines available in record time. Even in the absence of approved vaccines or therapeutics for this type of Ebola, Uganda was able to use proven public health tools to contain the outbreak.”
FILE – WHO – KAMPALA
3. Various shots, healthcare worker fitting PPE, gloves and boots
4. Various shots, nurses attending to mother and child
5. Close up, Ebola Prevention information board
11 JANUARY 2023, JOHANNESBURG, SOUTH AFRICA
6. SOUNDBITE (English) Dr Matshidiso Moeti, Regional Director for Africa, WHO:
“Soon after Uganda declared the Sudan ebolavirus outbreak, we worked with vaccine developers, donors and the Ugandan health authorities to identify candidate therapeutics and vaccines for inclusion in trials. Three candidate vaccines were identified, and the first doses arrived in the country on 8 December 2022, constituting a historic milestone in the global capacity to respond to outbreaks and prevent them from becoming pandemics.”
FILE – WHO – KAMPALA,
7. Med shot, WHO staff talking to healthcare worker
8. Close up, WHO branded packaging
9. Med shot, healthcare worker unboxing supplies
11 JANUARY 2023, JOHANNESBURG, SOUTH AFRICA
10. SOUNDBITE (English) Dr Matshidiso Moeti, Regional Director for Africa, WHO:
“As the outbreak officially ends today, it is essential that we review the response and lessons learned in view of future outbreaks. The key role that communities play was amply demonstrated in this response and its initial challenges. We also saw the need to engage the entire health system, including the private sector.”
FILE – WHO – KAMPALA
11. Various shots of participants in workshop and WHO making notes on a whiteboard.
FILE – WHO – KAMPALA
1. Various shots, Kampala
11 JANUARY 2023, GENEVA, SWITZERLAND
2. SOUNDBITE (English) Dr Tedros Adhanom Ghebreyesus, Director-General, WHO:
“Today marks the end of the Ebola outbreak in Uganda, four months after the first cases were reported. I congratulate the government, the people of Uganda and health workers, some of whom lost their lives, for their leadership and dedication in bringing this outbreak to an end. We thank donors and partners for swiftly mobilizing resources, and vaccine developers for making candidate vaccines available in record time. Even in the absence of approved vaccines or therapeutics for this type of Ebola, Uganda was able to use proven public health tools to contain the outbreak.”
FILE – WHO – KAMPALA
3. Various shots, healthcare worker fitting PPE, gloves and boots
4. Various shots, nurses attending to mother and child
5. Close up, Ebola Prevention information board
11 JANUARY 2023, JOHANNESBURG, SOUTH AFRICA
6. SOUNDBITE (English) Dr Matshidiso Moeti, Regional Director for Africa, WHO:
“Soon after Uganda declared the Sudan ebolavirus outbreak, we worked with vaccine developers, donors and the Ugandan health authorities to identify candidate therapeutics and vaccines for inclusion in trials. Three candidate vaccines were identified, and the first doses arrived in the country on 8 December 2022, constituting a historic milestone in the global capacity to respond to outbreaks and prevent them from becoming pandemics.”
FILE – WHO – KAMPALA,
7. Med shot, WHO staff talking to healthcare worker
8. Close up, WHO branded packaging
9. Med shot, healthcare worker unboxing supplies
11 JANUARY 2023, JOHANNESBURG, SOUTH AFRICA
10. SOUNDBITE (English) Dr Matshidiso Moeti, Regional Director for Africa, WHO:
“As the outbreak officially ends today, it is essential that we review the response and lessons learned in view of future outbreaks. The key role that communities play was amply demonstrated in this response and its initial challenges. We also saw the need to engage the entire health system, including the private sector.”
FILE – WHO – KAMPALA
11. Various shots of participants in workshop and WHO making notes on a whiteboard.
STORYLINE
WHO Director-General marked today the end of the Ebola outbreak in Uganda, four months after the first cases were reported, saying the country “was able to use proven public health tools to contain the outbreak.” WHO
“I congratulate the government, the people of Uganda and health workers, some of whom lost their lives, for their leadership and dedication in bringing this outbreak to an end. We thank donors and partners for swiftly mobilizing resources, and vaccine developers for making candidate vaccines available in record time. Even in the absence of approved vaccines or therapeutics for this type of Ebola, Uganda was able to use proven public health tools to contain the outbreak. “
It was the country’s first Sudan ebolavirus outbreak in a decade and its fifth overall for this kind of Ebola. In total there were 164 cases (142 confirmed and 22 probable), 55 confirmed deaths and 87 recovered patients. More than 4000 people who came in contact with confirmed cases were followed up and their health monitored for 21 days. Overall, the case-fatality ratio was 47 percent. The last patient was released from care on 30 November when the 42-day countdown to the end of the outbreak began.
This Ebola outbreak was caused by the Sudan ebolavirus, one of six species of the Ebola virus against which no therapeutics and vaccines have been approved yet.
Dr Matshidiso Moeti, WHO Regional Director for Africa, said “Soon after Uganda declared the Sudan ebolavirus outbreak, we worked with vaccine developers, donors and the Ugandan health authorities to identify candidate therapeutics and vaccines for inclusion in trials. Three candidate vaccines were identified, and the first doses arrived in the country on 8 December 2022, constituting a historic milestone in the global capacity to respond to outbreaks and prevent them from becoming pandemics.”
WHO and partners supported Ugandan health authorities from the outset of the outbreak, deploying experts, providing training in contact tracing, testing and patient care, as well as building isolation and treatment centres and providing laboratory testing kits. The Organization provided nearly US$ 6.5 million to Uganda’s response and an additional US$ 3 million to support readiness in six neighbouring countries.
For Moeti, “as the outbreak officially ends today, it is essential that we review the response and lessons learned in view of future outbreaks. The key role that communities play was amply demonstrated in this response and its initial challenges. We also saw the need to engage the entire health system, including the private sector.”
“I congratulate the government, the people of Uganda and health workers, some of whom lost their lives, for their leadership and dedication in bringing this outbreak to an end. We thank donors and partners for swiftly mobilizing resources, and vaccine developers for making candidate vaccines available in record time. Even in the absence of approved vaccines or therapeutics for this type of Ebola, Uganda was able to use proven public health tools to contain the outbreak. “
It was the country’s first Sudan ebolavirus outbreak in a decade and its fifth overall for this kind of Ebola. In total there were 164 cases (142 confirmed and 22 probable), 55 confirmed deaths and 87 recovered patients. More than 4000 people who came in contact with confirmed cases were followed up and their health monitored for 21 days. Overall, the case-fatality ratio was 47 percent. The last patient was released from care on 30 November when the 42-day countdown to the end of the outbreak began.
This Ebola outbreak was caused by the Sudan ebolavirus, one of six species of the Ebola virus against which no therapeutics and vaccines have been approved yet.
Dr Matshidiso Moeti, WHO Regional Director for Africa, said “Soon after Uganda declared the Sudan ebolavirus outbreak, we worked with vaccine developers, donors and the Ugandan health authorities to identify candidate therapeutics and vaccines for inclusion in trials. Three candidate vaccines were identified, and the first doses arrived in the country on 8 December 2022, constituting a historic milestone in the global capacity to respond to outbreaks and prevent them from becoming pandemics.”
WHO and partners supported Ugandan health authorities from the outset of the outbreak, deploying experts, providing training in contact tracing, testing and patient care, as well as building isolation and treatment centres and providing laboratory testing kits. The Organization provided nearly US$ 6.5 million to Uganda’s response and an additional US$ 3 million to support readiness in six neighbouring countries.
For Moeti, “as the outbreak officially ends today, it is essential that we review the response and lessons learned in view of future outbreaks. The key role that communities play was amply demonstrated in this response and its initial challenges. We also saw the need to engage the entire health system, including the private sector.”
Category
Topical Subjects
Personal Subjects
Geographic Subjects
Corporate Subjects
Source
Alternate Title
unifeed230111e